Intersect ENT Inc.

(NASDAQ: XENT) Trade

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Intersect ENT Inc are a commercial drug delivery company committed to improving the quality of life for patients with ear, nose and throat conditions. It offer's PROPEL and PROPEL mini drug-releasing implants for patients undergoing sinus surgery to treat chronic sinusitis and PROPEL contour, a steroid-releasing implant to frontal and maxillary sinus ostia or openings of the dependent sinuses. The company generates revenues from the sale of our PROPEL family of products.

Contact Information

Website: www.intersectent.com
Email: ir@intersectENT.com
Main Phone: +1 650 641-2100
Address: 1555 Adams Drive
State: CA
City / Town: Menlo Park
Country: US
Postal Code: 94025

Issuer Information

Exchange: NSD
CEO: Thomas A. West
Employees: 406
NAICS: Surgical and Medical Instrument Manufacturing(339112)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A